Altogether, these data demonstrate that GILZ expression is lower in livers of human NASH and NAFLD patients presenting fibrosis compared to healthy controls, and that its expression inversely correlates with the expression of CCL2. The gene discussed is CCL2; the disease is metabolic dysfunction-associated steatohepatitis.